Annual Accounts Payable
$2.94 M
-$19.12 M-86.68%
December 31, 2024
Summary
- As of March 8, 2025, AMLX annual accounts payable is $2.94 million, with the most recent change of -$19.12 million (-86.68%) on December 31, 2024.
- During the last 3 years, AMLX annual accounts payable has fallen by -$1.43 million (-32.78%).
- AMLX annual accounts payable is now -86.68% below its all-time high of $22.06 million, reached on December 31, 2023.
Performance
AMLX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.94 M
+$1.45 M+97.65%
December 31, 2024
Summary
- As of March 8, 2025, AMLX quarterly accounts payable is $2.94 million, with the most recent change of +$1.45 million (+97.65%) on December 31, 2024.
- Over the past year, AMLX quarterly accounts payable has dropped by -$19.12 million (-86.68%).
- AMLX quarterly accounts payable is now -88.10% below its all-time high of $24.70 million, reached on June 30, 2023.
Performance
AMLX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMLX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.7% | -86.7% |
| 3 y3 years | -32.8% | -53.9% |
| 5 y5 years | +33.9% | -53.9% |
AMLX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.7% | at low | -88.1% | +97.7% |
| 5 y | 5-year | -86.7% | +33.9% | -88.1% | +97.7% |
| alltime | all time | -86.7% | +33.9% | -88.1% | +97.7% |
Amylyx Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.94 M(-86.7%) | $2.94 M(+97.6%) |
| Sep 2024 | - | $1.49 M(-70.0%) |
| Jun 2024 | - | $4.96 M(-76.9%) |
| Mar 2024 | - | $21.45 M(-2.8%) |
| Dec 2023 | $22.06 M(+252.6%) | $22.06 M(+246.3%) |
| Sep 2023 | - | $6.37 M(-74.2%) |
| Jun 2023 | - | $24.70 M(+129.3%) |
| Mar 2023 | - | $10.77 M(+72.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $6.26 M(+43.1%) | $6.26 M(-11.3%) |
| Sep 2022 | - | $7.05 M(-13.1%) |
| Jun 2022 | - | $8.12 M(-19.2%) |
| Mar 2022 | - | $10.04 M(+129.8%) |
| Dec 2021 | $4.37 M(+21.0%) | $4.37 M(+44.5%) |
| Sep 2021 | - | $3.03 M(-16.2%) |
| Dec 2020 | $3.61 M(+64.6%) | $3.61 M |
| Dec 2019 | $2.19 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual accounts payable year-on-year change?
- What is Amylyx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly accounts payable year-on-year change?
What is Amylyx Pharmaceuticals annual accounts payable?
The current annual accounts payable of AMLX is $2.94 M
What is the all time high annual accounts payable for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual accounts payable is $22.06 M
What is Amylyx Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AMLX annual accounts payable has changed by -$19.12 M (-86.68%)
What is Amylyx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AMLX is $2.94 M
What is the all time high quarterly accounts payable for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly accounts payable is $24.70 M
What is Amylyx Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AMLX quarterly accounts payable has changed by -$19.12 M (-86.68%)